AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 27682229
Drug: Internet-based problem-solving
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet-based problem-solving treatment (IPST)
Trial: 26007680
Drug: Systemic administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic administration of antibiotics (Amoxicillin + Metronidazole)
Trial: 21123447
Drug: Low-dose folic
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose folic acid (0.4 mg/d)
Trial: 15899653
Drug: Antioxidant supplementation
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant supplementation (vitamins C and E, beta-carotene, and selenium) along with methimazole therapy
Trial: 15899653
Drug: Methimazole therapy
RxNorm normalized name: Methimazole
DrugBank: Methimazole (DB00763)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methimazole therapy alone
Trial: 2677301
Drug: Flurbiprofen, 50
RxNorm normalized name: Flurbiprofen, 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurbiprofen, 50 mg b.i.d.
Trial: 20737210
Drug: Oral 5-aminosalicylic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral 5-aminosalicylic acid (5-ASA) alone
Trial: 20737210
Drug: Oral 5-ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral 5-ASA plus oral Lactobacillus casei DG
Trial: 20737210
Drug: Oral 5-ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral 5-ASA and rectal Lactobacillus casei DG
Trial: 16634751
Drug: Aspirin 100
RxNorm normalized name: aspirin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 100 mg day(-1) for 1 week
Trial: 16634751
Drug: Clopidogrel (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (300 mg on day 1, then 75 mg day(-1)) for 1 week
Trial: 16634751
Drug: Aspirin and
RxNorm normalized name: Aspirin and Caffeine Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin and Clopidogrel
Trial: 8629306
Drug: Triple drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple drug therapy with a 10-day course of OKT3 (group 2, n = 44)
Trial: 8629306
Drug: Triple drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple drug therapy with anti-interleukin-2 receptor monoclonal antibody LO-Tact-1 (group 3, n = 43)
Trial: 8629306
Drug: Triple drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple drug therapy (cyclosporine, steroids, and azathioprine; group 1, n = 42)
Trial: 8629306
Drug: OKT3 therapy
RxNorm normalized name: tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: OKT3 therapy (group 2)
Trial: 8629306
Drug: LO-Tact-1 therapy
RxNorm normalized name: Tact
DrugBank: Diphenhydramine (DB01075)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: LO-Tact-1 therapy (group 3)
Trial: 1424170
Drug: Parlodel LAR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parlodel LAR 25 mg
Trial: 1424170
Drug: Parlodel LAR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parlodel LAR 50 mg
Trial: 1424170
Drug: Parlodel LAR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parlodel LAR 100 mg
Trial: 2413294
Drug: Captopril (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (2 mg . kg‐1)
Trial: 29307093
Drug: Stopping TNF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stopping TNF inhibitors (TNFi) therapy
Trial: 29307093
Drug: Continuing TNF
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuing TNF inhibitors (TNFi) therapy
Trial: 27129011
Drug: Topiramate 75
RxNorm normalized name: Topiramate
DrugBank: Topiramate (DB00273)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Topiramate 75 mg every 12 hours and Diltiazem 240 mg/day
Trial: 27129011
Drug: Topiramate 96
RxNorm normalized name: Topiramate
DrugBank: Topiramate (DB00273)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Topiramate 96 mg every 12 hours and Hydrochlorothiazide 25 mg/day
Trial: 27129011
Drug: Topiramate 100
RxNorm normalized name: topiramate 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate 100 mg every 12 hours and Propranolol 40-80 mg every 12 hours
Trial: 20334647
Drug: Inhaled Insulin
RxNorm normalized name: insulin, regular, human Inhalation Powder [Afrezza]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled Insulin Treatment Questionnaire (IITQ)
Trial: 9263086
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g of cefamandole at induction of anesthesia (group 1, n = 24)
Trial: 9263086
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g of cefamandole at the beginning of anesthesia followed by an additional dose (2 g) immediately after onset of cardiopulmonary bypass (CPB) (group 2, n = 22)
Trial: 9263086
Drug: 4 g
RxNorm normalized name: CTX4 Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g of cefamandole just at the initiation of anesthesia (group 3, n = 23)
Trial: 7508065
Drug: Captopril 12.5
RxNorm normalized name: captopril 12.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 12.5 mg three times daily
Trial: 3533236
Drug: Pancuronium 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pancuronium 0.5 mg (approximately 0.007 mg X kg‐1)
Trial: 3533236
Drug: Pancuronium 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pancuronium 1.0 mg (approximately 0.015 mg X kg‐1)
Trial: 3533236
Drug: d-tubocurarine 0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-tubocurarine 0.05 mg X kg‐1
Trial: 3533236
Drug: d-tubocurarine 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d-tubocurarine 0.1 mg X kg‐1
Trial: 26763075
Drug: Sanguinarine (SA)
RxNorm normalized name: sanguinarine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sanguinarine (SA) at 10 mg kg(‐1) BW
Trial: 26763075
Drug: Sanguinarine (SA)
RxNorm normalized name: sanguinarine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sanguinarine (SA) at 0, 5, 10 and 20 mg kg(‐1) BW
Trial: 22139591
Drug: LTG XR
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LTG XR 300 mg/day
Trial: 22139591
Drug: LTG XR
RxNorm normalized name: isopropyl alcohol
DrugBank: Isopropyl alcohol (DB02325)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LTG XR 250 mg/day
Trial: 16146552
Drug: Simvastatin 5-10
RxNorm normalized name: simvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 5-10 mg/d for 4 years
Trial: 10815342
Drug: Post-assistance programme
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-assistance programme (nine-months with 36 sessions of psychoanalytic group therapy)
Trial: 8829887
Drug: Core cooling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Core cooling via intravenous infusion of cold saline
Trial: 6531663
Drug: Beta-blockade (propranolol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blockade (propranolol, 100 mg orally)
Trial: 30914073
Drug: BD+50 mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BD+50 mg EEO/kg
Trial: 30914073
Drug: BD+100 mg
RxNorm normalized name: BD
DrugBank: Butylene glycol (DB14110)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BD+100 mg EEO/kg
Trial: 30914073
Drug: BD+150 mg
RxNorm normalized name: BD
DrugBank: Butylene glycol (DB14110)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BD+150 mg OEO/kg
Trial: 30914073
Drug: BD+300 mg
RxNorm normalized name: BD
DrugBank: Butylene glycol (DB14110)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BD+300 mg OEO/kg
Trial: 29044707
Drug: Cholecalciferol (300,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholecalciferol (300,000 IU, two doses at baseline and 8 weeks)
Trial: 26998954
Drug: Ilaprazole 5
RxNorm normalized name: ilaprazole
DrugBank: Ilaprazole (DB11964)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ilaprazole 5 mg intravenously
Trial: 26998954
Drug: Ilaprazole 10
RxNorm normalized name: ilaprazole
DrugBank: Ilaprazole (DB11964)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ilaprazole 10 mg intravenously
Trial: 26998954
Drug: Ilaprazole 20
RxNorm normalized name: ilaprazole
DrugBank: Ilaprazole (DB11964)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ilaprazole 20 mg intravenously
Trial: 26998954
Drug: Ilaprazole 10
RxNorm normalized name: ilaprazole
DrugBank: Ilaprazole (DB11964)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ilaprazole 10 mg orally
Trial: 11820865
Drug: TMZ 10
RxNorm normalized name: TMZ
DrugBank: Temozolomide (DB00853)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: TMZ 10 mg
Trial: 11820865
Drug: TMZ 20
RxNorm normalized name: TMZ
DrugBank: Temozolomide (DB00853)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: TMZ 20 mg
Trial: 11820865
Drug: TMZ 40
RxNorm normalized name: TMZ
DrugBank: Temozolomide (DB00853)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: TMZ 40 mg
Trial: 11820865
Drug: TMZ 80
RxNorm normalized name: TMZ
DrugBank: Temozolomide (DB00853)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: TMZ 80 mg
Trial: 10424325
Drug: Atovaquone alone
RxNorm normalized name: Atovaquone
DrugBank: Atovaquone (DB01117)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atovaquone alone (1000 mg)
Trial: 10424325
Drug: Atovaquone with
RxNorm normalized name: Atovaquone
DrugBank: Atovaquone (DB01117)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atovaquone with proguanil (1000 mg + 400 mg)
Trial: 10424325
Drug: Proguanil alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proguanil alone (400 mg)
Trial: 10424325
Drug: Proguanil with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proguanil with atovaquone (400 mg + 1000 mg)
Trial: 7802104
Drug: Low-dose amisulpride
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose amisulpride
Trial: 2104072
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg diazepam intravenously rapidly over 2‐4 s (Group A)
Trial: 2104072
Drug: Diazepam intravenously
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam intravenously over 1‐2 min, mean dose 15.9 mg (Group B)
Trial: 31934844
Drug: Ordinary care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ordinary care and treatment in primary care (reference group)
Trial: 28244124
Drug: Early endoscopy
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early endoscopy and possible treatment escalation
Trial: 24201169
Drug: Transdermal continuous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal continuous oxygen therapy (TCOT) for 4 weeks as an adjunct to standard care.
Trial: 24201169
Drug: Transdermal continuous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal continuous oxygen therapy (TCOT).
Trial: 19286091
Drug: SCH 530348
RxNorm normalized name: SCH 58500
DrugBank: SCH-58500 (DB17416)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCH 530348 10 mg
Trial: 19286091
Drug: SCH 530348
RxNorm normalized name: SCH 58500
DrugBank: SCH-58500 (DB17416)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCH 530348 20 mg
Trial: 19286091
Drug: SCH 530348
RxNorm normalized name: SCH 58500
DrugBank: SCH-58500 (DB17416)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCH 530348 40 mg
Trial: 19286091
Drug: SCH 530348
RxNorm normalized name: SCH 58500
DrugBank: SCH-58500 (DB17416)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCH 530348 0.5 mg
Trial: 19286091
Drug: SCH 530348
RxNorm normalized name: SCH 58500
DrugBank: SCH-58500 (DB17416)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCH 530348 1.0 mg
Trial: 19286091
Drug: SCH 530348
RxNorm normalized name: SCH 58500
DrugBank: SCH-58500 (DB17416)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCH 530348 2.5 mg
Trial: 17398194
Drug: Ezetimibe/simvastatin 10/40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe/simvastatin 10/40 mg/day
Trial: 18266544
Drug: Functional Family
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Functional Family Therapy (FFT)
Trial: 24884894
Drug: Raised fasting
RxNorm normalized name: Fast Freeze
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raised fasting blood glucose or currently on medication for diabetes
Trial: 22415888
Drug: Aliskiren 300mg
RxNorm normalized name: ALISKIREN 300MG TAB
DrugBank: Aliskiren (DB09026)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aliskiren 300mg plus Losartan 100mg daily for 36 weeks
Trial: 22415888
Drug: Losartan 100mg
RxNorm normalized name: LOSARTAN 100MG TAB
DrugBank: Losartan (DB00678)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Losartan 100mg daily for 36 weeks
Trial: 12097848
Drug: SonoVue (BR1)
DrugBank: Sulfur hexafluoride (DB11104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SonoVue (BR1) at a dose of 1.2 ml
Trial: 12097848
Drug: SonoVue (BR1)
DrugBank: Sulfur hexafluoride (DB11104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SonoVue (BR1) at a dose of 2.4 ml
Trial: 12097848
Drug: SonoVue (BR1)
DrugBank: Sulfur hexafluoride (DB11104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SonoVue (BR1) at doses of 0.3, 0.6, 1.2, and 2.4 ml
Trial: 7586113
Drug: Atropine 20
RxNorm normalized name: Minims Homatropine 20 MG/ML Ophthalmic Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine 20 micrograms.kg‐1 and succinylcholine 1.5 mg.kg‐1 (n = 20)
Trial: 7586113
Drug: Succinylcholine 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Succinylcholine 1.5 mg.kg‐1 alone (n = 21)
Trial: 2275907
Drug: 1.5% lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5% lidocaine (L)
Trial: 29901598
Drug: Interscalene block
RxNorm normalized name: Ivy Block
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interscalene block using ropivacaine 0.25% 10 mL including dexamethasone 5 mg
Trial: 22325115
Drug: Intracervical 2%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracervical 2% lidocaine gel
Trial: 20455705
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (12 mg for women, 15 mg for men) for 18 months
Trial: 17039265
Drug: Sequential doxorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential doxorubicin 75 mg/M2 q2 wks x 3 and docetaxel 40 mg/M2 weekly x 6
Trial: 15752394
Drug: Cisatracurium (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisatracurium (0.1 mg kg(‐1))
Trial: 15752394
Drug: Vecuronium (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vecuronium (0.1 mg kg(‐1))
Trial: 15752394
Drug: Rocuronium (0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium (0.6 mg kg(‐1))
Trial: 2146060
Drug: Isradipine (twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isradipine (twice a day)
Trial: 2146060
Drug: Hydrochlorothiazide (twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (twice a day)
Trial: 21372740
Drug: Drug therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug therapy alone (group C)
Trial: 10497445
Drug: Specific immunotherapy
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific immunotherapy (sIT) applied in 29 patients with pollinosis and 27 patients sensitive to house dust mite.
Trial: 10497445
Drug: Routine pharmacotherapy
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine pharmacotherapy alone (control group).
Trial: 26631095
Drug: Testosterone undecanoate
RxNorm normalized name: Testosterone Undecanoate
DrugBank: Testosterone undecanoate (DB13946)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone undecanoate 40 mg twice weekly with daily oral estrogen
Trial: 26631095
Drug: Placebo twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo twice weekly with daily oral estrogen
Trial: 20886631
Drug: 5-fluorouracil or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-fluorouracil or equivalent agents
Trial: 19041049
Drug: Dofetilide (class
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dofetilide (class III antiarrhythmic drug)
Trial: 16609032
Drug: l-selenomethionine (SeMet)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-selenomethionine (SeMet)
Trial: 11535875
Drug: Aspirin (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (160 or 300 mg/day)
Trial: 3323604
Drug: Cyclosporine A
RxNorm normalized name: CycloSPORINE A
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine A (CyA) + Heparin
Trial: 22796948
Drug: Bagel with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bagel with cream cheese and juice (400 kcal)
Trial: 20399951
Drug: Advanced supply
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Advanced supply of emergency contraception (EC) pills with unlimited supply thereafter upon request
Trial: 8445015
Drug: Estradiol (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estradiol (0.2 mg/day percutaneously)
Trial: 8445015
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no estradiol treatment)
Trial: 3518730
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg trimoprostil administered 30 min before meals
Trial: 3518730
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg trimoprostil administered 30 min after meals
Trial: 26432623
Drug: Basal-Bolus Insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Basal-Bolus Insulin (B-BI)
Trial: 26432623
Drug: Sliding Scale
RxNorm normalized name: wing scale pollen extract
DrugBank: Atriplex canescens pollen (DB10767)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sliding Scale Insulin (SSI)
Trial: 24338466
Drug: Intrathecal 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal 7.5 mg Levobupivacaine 0.25% plus sufentanil 2.5 μg (Group L0.25)
Trial: 24338466
Drug: Intrathecal 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal 7.5 mg Levobupivacaine 0.50% plus sufentanil 2.5 μg (GroupControl)
Trial: 21289522
Drug: AT-101 (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AT-101 (40 mg b.i.d. × 3 days) plus docetaxel (75 mg/m on day 1) every 21 days
Trial: 21289522
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus docetaxel (75 mg/m on day 1) every 21 days
Trial: 19649687
Drug: Morphine (MG)
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Morphine (MG)
Trial: 19649687
Drug: Oxycodone (OG)
DrugBank: Oxycodone (DB00497)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxycodone (OG)
Trial: 21280077
Drug: Glatiramer acetate
RxNorm normalized name: Glatiramer Acetate
DrugBank: Glatiramer (DB05259)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glatiramer acetate 40 mg
Trial: 21280077
Drug: Glatiramer acetate
RxNorm normalized name: Glatiramer Acetate
DrugBank: Glatiramer (DB05259)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glatiramer acetate 20 mg
Trial: 15035723
Drug: Sodium antimony
RxNorm normalized name: Sodium antimonyl gluconate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium antimony gluconate (SAG) 20 mg/kg daily for 4 weeks
Trial: 15035723
Drug: Amphotericin B
RxNorm normalized name: Amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amphotericin B (AMB) 1 mg/kg daily for 20 days
Trial: 8154037
Drug: DILT (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DILT (60 mg b.i.d.)
Trial: 8154037
Drug: KETO (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KETO (200 mg/day)
Trial: 8154037
Drug: Control (TRIPLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (TRIPLE with CsA 8 mg/kg/day)
Trial: 3292185
Drug: Amoxicillin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin (3 g as a single dose)
Trial: 3292185
Drug: Clindamycin (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clindamycin (600 mg as a single dose)
Trial: 3292185
Drug: Erythromycin (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin (1.5 g plus another 0.5 g after six hours)
Trial: 28283600
Drug: Admission hyperglycemia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Admission hyperglycemia (blood glucose ≥7.8 mmol/L)
Trial: 26585940
Drug: Mammalian cell-derived
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mammalian cell-derived quadrivalent influenza vaccine (QIVc)
Trial: 26585940
Drug: Trivalent influenza
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trivalent influenza vaccines (TIV1c/TIV2c)
Trial: 24251363
Drug: Standard dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dosing of warfarin (control)
Trial: 21334545
Drug: Augmented soft
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Augmented soft tissue mobilization (ASTM) twice a week for 5 weeks
Trial: 8569932
Drug: Pyloriset IgG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyloriset IgG at a cut-off value of 500 U/l
Trial: 8569932
Drug: Pyloriset IgG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyloriset IgG at a cut-off value of 350 U/l (excluding patients aged above 70 years)
Trial: 2548135
Drug: 0.625 mg
RxNorm normalized name: estrone 0.625 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.625 mg conjugated equine estrogens + 5 mg medroxyprogesterone acetate
Trial: 2548135
Drug: 1.25 mg
RxNorm normalized name: menthol 1.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.25 mg conjugated equine estrogens + 5 mg medroxyprogesterone acetate
Trial: 2548135
Drug: 0.625 mg
RxNorm normalized name: estrone 0.625 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.625 mg conjugated equine estrogens + placebo